Last Updated: November 8, 2026

DIFLORASONE DIACETATE Drug Patent Profile

Name: DIFLORASONE DIACETATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Diflorasone Diacetate, and what generic alternatives are available?

Diflorasone Diacetate is a drug marketed by Ani Pharms, Avondale Pharms, Sun Pharma Canada, Rising, Sciegen Pharms, and The J Molner. and is included in eight NDAs.

The generic ingredient in DIFLORASONE DIACETATE is diflorasone diacetate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the diflorasone diacetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Diflorasone Diacetate

A generic version of DIFLORASONE DIACETATE was approved as diflorasone diacetate by AVONDALE PHARMS on April 27^th, 1999.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for DIFLORASONE DIACETATE?
What are the global sales for DIFLORASONE DIACETATE?
What is Average Wholesale Price for DIFLORASONE DIACETATE?

Summary for DIFLORASONE DIACETATE

US Patents:	0
Applicants:	6
NDAs:	8
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	61
Patent Applications:	6,774
Drug Prices:	Drug price information for DIFLORASONE DIACETATE
DailyMed Link:	DIFLORASONE DIACETATE at DailyMed

Drug patent expirations by year for DIFLORASONE DIACETATE

Pharmacology for DIFLORASONE DIACETATE

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Anatomical Therapeutic Chemical (ATC) Classes for DIFLORASONE DIACETATE

D07AC	Corticosteroids, potent (group III)
D07A	CORTICOSTEROIDS, PLAIN
D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

US Patents and Regulatory Information for DIFLORASONE DIACETATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	DIFLORASONE DIACETATE	diflorasone diacetate	CREAM;TOPICAL	076263-001	Dec 20, 2002		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharma Canada	DIFLORASONE DIACETATE	diflorasone diacetate	OINTMENT;TOPICAL	075331-001	May 14, 1999	AB	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Avondale Pharms	DIFLORASONE DIACETATE	diflorasone diacetate	OINTMENT;TOPICAL	075374-001	Apr 27, 1999	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
The J Molner	DIFLORASONE DIACETATE	diflorasone diacetate	OINTMENT;TOPICAL	210753-001	Jun 12, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Avondale Pharms	DIFLORASONE DIACETATE	diflorasone diacetate	CREAM;TOPICAL	075187-001	Mar 30, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharma Canada	DIFLORASONE DIACETATE	diflorasone diacetate	CREAM;TOPICAL	075508-001	Apr 24, 2000	BX	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	DIFLORASONE DIACETATE	diflorasone diacetate	OINTMENT;TOPICAL	206572-001	Jul 24, 2015		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.